EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Drug‐Coated Balloons Versus Other Percutaneous Coronary Intervention Strategies in De Novo Coronary Artery Disease: A Systematic Review, Meta‐Analysis With Trial Sequential Analysis

Yue Yu iD, Yue Miao Jiao iD, Yang Li iD, Ming Zhang iD, Guang Yuan Song iD, Cheng Qian Yin iD

Cardiovascular Therapeutics · 2026

DOI: 10.1155/cdr/5568664 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cardiovascular Therapeutics, 2026. Verfasst von Yue Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China, ccmu.edu.cn. Hauptthemen laut MEDLINE: Coronary Artery Disease, Coated Materials, Biocompatible, Angioplasty, Balloon, Coronary, Cardiac Catheters. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug‐coated balloons (DCBs) present a viable option distinct from drug‐eluting stents (DESs) in addressing coronary artery disease (CAD), particularly when it comes to in‐stent restenosis (ISR) scenarios. The utilization of DCBs marks a significant deviation from traditional DES applications. For CAD patients experiencing ISR, DCBs offer an innovative pathway to treatment. However, their efficacy and safety in de novo CAD lesions remain uncertain. This meta‐analysis evaluates DCB versus other percutaneous coronary intervention (PCI) strategies, including DES, bare‐metal stents (BMSs), and plain old balloon angioplasty (POBA), in de novo CAD.

Methods

A comprehensive search was conducted across PubMed, Embase, Web of Science, and the Cochrane Central Register of Controlled Trials (CENTRAL), spanning from their inception up until November 14, 2024. Studies included were randomized controlled trials (RCTs) and cohort studies, which assessed DCB against alternative PCI strategies in patients with de novo CAD. The key outcome measures focused on major adverse cardiac events (MACEs) as well as late lumen loss (LLL). Trial sequential analysis (TSA) assessed the robustness of findings.

Results

Fifty studies (19 RCTs, 31 cohort studies) involving 28,292 patients were analyzed. DCB showed a lower MACE incidence compared to noncoated devices (RR = 0.52, 95% CI: 0.40–0.69) but no significant difference versus DES (RR = 0.96, 95% CI: 0.84–1.10). DCB significantly reduced LLL compared to all controls (MD = −0.22, 95% CI: −0.29 to −0.14). Subgroup analyses confirmed DCB′s safety across indications, ethnicities, comorbidities, and dual antiplatelet therapy (DAPT) durations, with reduced LLL in small vessel disease and shorter DAPT. TSA supported LLL findings but indicated inconclusive MACE results in RCTs, necessitating further research.

Conclusion

DCB is a safe and effective alternative to DES in de novo CAD, with comparable safety and superior LLL reduction. However, MACE results in RCTs require further validation. Future studies should explore long‐term outcomes and integrate newer‐generation DCB and DES technologies to optimize clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseCoated Materials, BiocompatibleAngioplasty, Balloon, CoronaryCardiac CathetersPercutaneous Coronary InterventionCardiovascular AgentsHumansTreatment OutcomeRandomized Controlled Trials as TopicRisk FactorsFemaleMaleMiddle AgedRisk AssessmentAgedTime FactorsDrug-Eluting Stents

Stichwörter der Autor:innen

de novo coronary artery diseasedrug-coated balloonsmeta-analysespercutaneous coronary interventionstrial sequential analyses

Substanzen

Coated Materials, BiocompatibleCardiovascular Agents

Autor:innen und Institutionen

  • Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China, ccmu.edu.cn.

ORCID-Profile: Yue Yu, Yue Miao Jiao, Yang Li, Ming Zhang, Guang Yuan Song, Cheng Qian Yin

Förderung

  • National Science and Technology Major Project

Zitieren

APA

Yu, Y., Jiao, Y. M., Li, Y., Zhang, M., Song, G. Y., & Yin, C. Q. (2026). Drug‐Coated Balloons Versus Other Percutaneous Coronary Intervention Strategies in De Novo Coronary Artery Disease: A Systematic Review, Meta‐Analysis With Trial Sequential Analysis. Cardiovascular Therapeutics. https://doi.org/10.1155/cdr/5568664

Vancouver

Yu Y, Jiao YM, Li Y, Zhang M, Song GY, Yin CQ. Drug‐Coated Balloons Versus Other Percutaneous Coronary Intervention Strategies in De Novo Coronary Artery Disease: A Systematic Review, Meta‐Analysis With Trial Sequential Analysis. Cardiovascular Therapeutics. 2026. doi:10.1155/cdr/5568664

BibTeX
@article{Yu2026,
  author = {Yu, Yue and Jiao, Yue Miao and Li, Yang and Zhang, Ming and Song, Guang Yuan and Yin, Cheng Qian},
  title = {Drug‐Coated Balloons Versus Other Percutaneous Coronary Intervention Strategies in De Novo Coronary Artery Disease: A Systematic Review, Meta‐Analysis With Trial Sequential Analysis},
  journal = {Cardiovascular Therapeutics},
  year = {2026},
  doi = {10.1155/cdr/5568664}
}
Kostenlos starten →